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Abstract
The influence of diabetes on endothelial mechanisms implicated in the response of isolated rabbit carotid arteries to 5-hydroxytryp-
 .tamine 5-HT was studied. 5-HT induced a concentration–dependent contraction that was potentiated in arteries from diabetic rabbits
with respect to that in arteries from control rabbits. Endothelium removal potentiated 5-HT contractions in arteries from both control and
diabetic rabbits but increased the maximum effect only in arteries from diabetic rabbits. Incubation of arterial segments with
G  .N -nitro-L-arginine L-NA enhanced the contractile response to 5-HT. This L-NA enhancement was greater in arteries from diabetic
rabbits than in arteries from control rabbits. Aminoguanidine did not modify the 5-HT contraction in arteries from control and diabetic
rabbits. Indomethacin inhibited the 5-HT-induced response, and this inhibition was higher in arteries from control rabbits than in arteries
from diabetic rabbits. In summary, diabetes enhances the sensitivity of the rabbit carotid artery to 5-HT. In control animals, the
 .endothelium modulated the arterial response to 5-HT by the release of both nitric oxide NO and a vasoconstrictor prostanoid. Diabetes
enhances endothelial constitutive NO activity and impairs the production of the endothelial vasoconstrictor. q 2000 Elsevier Science B.V.
All rights reserved.
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1. Introduction
Several studies have demonstrated a correlation be-
tween diabetes and brain ischemia. Diabetes causes and
exacerbates macroangiopathies, increases the severity of
 .ischemia and increases stroke mortality Caplan, 1996 .
The epidemiological data obtained by the Epidemiology of
 .  .Diabetes Interventions and Complications EDIC 1999
have demonstrated that type-1 diabetic patients display an
increased intimal-medial thickness in the common and
internal carotid arteries. In addition, carotid occlusive dis-
ease is directly linked to 20–30% of strokes that occur
 .each year in the United States Eugene et al., 1999 .
The endothelium contributes to the regulation of vascu-
lar reactivity through the release of different constrictor
angiotensin II, endothelin-1, thromboxane A , prosta-2
.   .glandin H or relaxant nitric oxide NO , prostacyclin,2
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.endothelium-derived hyperpolarising factor substances, the
equilibrium of which results in vascular tone. Diabetes
alters the responsiveness of different vascular beds to
several vasoconstrictors and vasodilators, and it has been
hypothesised that endothelial dysfunction could partially
explain many of these altered responses. Nevertheless, the
mechanisms by which the impaired endothelial regulatory
function contributes to the abnormal vascular reactivity
have not been completely elucidated.
Several reports have suggested a possible role for 5-hy-
 .droxytryptamine 5-HT in the pathophysiology of diabetic
complications. Chronic diabetes is associated with a de-
crease in the cerebral concentration of 5-HT and with an
increase in the population of 5-HT and 5-HT receptors1A 2
 .in the rat brain Sandrini et al., 1997 . Diabetes reduces the
5-HT concentration in the gut and platelets of alloxan-
treated rats, these effects being reversed by treatment of
the animals with the serotonin precursor 5-hydroxytrypto-
 .phan Cicin-Sain and Jernej, 1996 . In contrast, a relation-
ship between increased 5-HT plasma levels and the devel-
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opment of diabetic nephropathy has been suggested Kasho
.et al., 1998 .
We have previously described several aspects of the
vasoconstrictor response of cerebral arteries to 5-HT, in-
cluding the modulatory influence of the endothelium
 .Miranda et al., 1993 , its dependence on the entry of
2q  .extracellular Ca Torregrosa et al., 1994 and the recep-
 .tors involved Miranda et al., 1995 . In addition, we have
reported that cerebral arteries exhibit hyperreactivity to
5-HT after subarachnoid hemorrhage via a mechanism that
involves the absence of the modulatory role of endothelial
 .NO Miranda et al., 1996 . The aim of the present study
was to analyse diabetes-induced changes in the reactivity
of the carotid artery to 5-HT, including the study of the
effects of the disease on the endothelial mechanisms that
regulate this response. To do this, we studied the influence
of alloxan-induced diabetes on the modulatory role of
endothelial-derived factors in the constrictor response of
rabbit carotid artery to 5-HT.
2. Materials and methods
Thirty-three male New Zealand white rabbits were used
in the present study. Animals were randomly divided into
two experimental groups: 17 in the control group and 16
destined for induction of experimental diabetes. Housing
conditions and experimental procedures were in accor-
dance with the European Union regulations on the use of
animals for scientific purposes 86r609rEEC, Article 5,
.Appendix II and promulgated by Spanish legislation on
 .March 14, 1988 R.D. 223r1988 .
2.1. Induction of diabetes and control animals
For induction of experimental diabetes, rabbits weigh-
ing 2.0–3.2 kg were sedated with intramuscular 40 mg of
 w .ketamine Ketolar . Diabetes was induced by injecting
 y1 .alloxan 100 mg kg into the lateral ear vein. To prevent
 .hypoglycaemia, 10 ml of 5% glucose was injected i.v.
after the alloxan and drinking water was supplemented
with 10% glucose for the first 24 h after the alloxan
injection. Thereafter, the animals were maintained on tap
water and regular food ad libitum for 6 weeks. A second
 .group of rabbits 2.1–3.0 kg was maintained under the
same conditions for the same time period to serve as
 .age-matched controls henceforth ‘‘control rabbits’’ . Dia-
betic rabbits showed a marked increase in serum glucose
and a failure to increase their body weight when compared
with control rabbits. Table 1 shows the mean values of
body weight and glycaemia before and 6 weeks after
diabetes induction for the rabbits in the diabetic group and
for the rabbits in the control group. Two rabbits that
received alloxan injection failed to become diabetic and
were excluded of the study.
Table 1
Body weight and glycaemia in control and diabetic rabbits
Body weight Glycaemia n
y1 .  .kg mmol l
Control rabbits
Initial time 2.55"0.09 5.9"0.2 17
6 weeks after 3.55"0.08 6.0"0.2 17
Diabetic rabbits
Initial time 2.49"0.09 6.0"0.2 16
a a6 weeks after 3.00"0.07 20.4"1.3 14
Results are means"S.E.M.
aSignificantly different from corresponding value in control rabbits,
P -0.05.
2.2. Isometric tension recording
Six weeks after diabetes induction, the diabetic and the
age-matched control rabbits were anaesthetised with
 .sodium thiopental sodium pentothal, 2% i.v. and killed
 y1by injection of potassium chloride 10 mEq, 0.5 ml kg ,
.i.v. . The common carotid arteries were dissected free and
cut into cylindrical segments measuring 4 mm in length.
Each segment was prepared for isometric tension recording
in an organ bath. Two stainless steel L-shaped pins diame-
.ter, 125 mm were introduced through the arterial lumen.
One pin was fixed to the organ bath wall and the other pin
was connected to a strain gauge for isometric tension
recording. The organ bath contained 5 ml of Ringer–Locke
solution that was bubbled continuously with 95% O and2
5% CO to provide a pH of 7.3–7.4. Temperature was2
kept at 378C. A resting tension of 2 g was applied to the
arterial segments, and they were allowed to equilibrate for
a period of 60–90 min before the experiments were started.
Tension was readjusted when necessary and the bath fluid
was changed every 15 min. After this period of equilibra-
tion, the reactivity of the arterial segments was checked by
depolarisation with 50 mM KCl. There were not signifi-
cant differences in the response to KCl between arteries
from control and diabetic rabbits.
2.3. Concentration–response cur˝es of 5-HT
The experiments were carried out with carotid arteries
from both control and diabetic rabbits. Concentration–
 y8 y5 .response curves for 5-HT 10 to 10 M were obtained
by its cumulative addition to the organ bath. To assess the
influence of the endothelium on the effect of 5-HT, con-
centration–response curves were obtained with arteries
from which the endothelium had been removed by rubbing
the intimal surface with a scored stainless steel rod rubbed
.arteries . The absence of endothelium was checked by
 .silver staining Caplan and Schwartz, 1973 . To assess the
participation of NO in the response of carotid arteries to
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Fig. 1. Concentration–contraction response curves for 5-HT in carotid
 .arteries isolated from control and diabetic rabbits with unrubbed and
 .without rubbed endothelium. Values represent means"S.E.M.
5-HT, the concentration–response curves for this amine
 .were obtained after incubation 20 min of the unrubbed
 . Garteries with the inhibitor of NO synthase NOS N -
 y4 .nitro-L-arginine L-NA, 10 M . Moreover, we examined
the possibility that NO synthesised by the inducible NOS
 .iNOS participated in the 5-HT-induced response by ob-
taining concentration–response curves for 5-HT in un-
 .rubbed arteries after incubation 20 min with aminoguani-
 y5 .dine 10 M , a selective inhibitor of the iNOS. To
examine the possibility that some arachidonic acid deriva-
tive could modulate the arterial response to 5-HT, we
obtained concentration–response curves for 5-HT after
 .incubation 20 min of the unrubbed arteries with indo-
 y5 .methacin 10 M , an inhibitor of cyclooxygenase. Fi-
nally, we also obtained concentration–response curves for
 y4 .5-HT in the presence of both L-NA 10 M and indo-
 y5 .methacin 10 M .
2.4. Drugs and solutions
Alloxan, 5-HT, aminoguanidine and indomethacin were
obtained from Sigma and L-NA from Peptide Institute.
Alloxan was dissolved in saline solution. 5-HT,
aminoguanidine and L-NA were dissolved in twice-dis-
tilled water and diluted in saline solution; the L-NA solu-
tion required sonication to dissolve completely. In-
domethacin was dissolved in ethanol and diluted in saline
solution. The composition of the Ringer–Locke solution
 .was mM : NaCl, 120; KCl, 5.4; CaCl , 2.2; MgCl , 1.0;2 2
NaHCO , 25; and glucose, 5.6. To prepare the KCl-de-3
polarising solution, NaCl was replaced by an equimolar
amount of KCl in the normal Ringer–Locke solution.
2.5. Statistical analysis
Comparisons of body weight and glycaemia between
control and diabetic rabbits were made by using unpaired
Student’s t-test. 5-HT-induced contractions are expressed
as a percentage of the previous depolarisation induced by
50 mM KCl. For each concentration–response curve the
 .maximum effect E and the concentration of 5-HTmax
 .which produced half of E EC were calculated.max 50
Maximum effects are expressed as means"standard error
 .of the mean S.E.M. and EC as the geometric mean50
 .with its confidence limits 95% for repeated experiments.
 .Statistical comparisons of E and ylogEC pDmax 50 2
values between arteries from control and diabetic rabbits
receiving the same experimental treatment were achieved
by using unpaired Student’s t-test. Comparisons between
the values of E and pD of the concentration–responsemax 2
curves for 5-HT obtained with the different treatments in
the arteries from the control rabbits were made using
 .analysis of variance ANOVA followed by the
Newman–Keuls test. The same tests were used to compare
the E and pD values of the curves obtained with themax 2
different treatments in the arteries from diabetic rabbits. A
probability value of less than 5% was considered signifi-
cant.
Table 2
 .EC and maximum effect E values for concentration–response50 max
curves for 5-HT in rabbit carotid artery
y7 .  .EC =10 M E % n50 max
Control rabbits
 .Control 3.1 2.9–3.5 86"6 51
a .Rubbed 1.2 1.0–1.5 101"8 15
y4 a a .L-NA 10 M 0.8 0.7–0.9 120"5 15
y5 a,b,c a,b,c .Indomethacin 10 M 5.4 5.0–5.7 37"3 19
y4 a,d d .L-NA 10 Mq 0.9 0.8–0.9 106"4 14
y5Indomethacin 10 M
y5  .Aminoguanidine 10 M 2.6 2.2–2.9 74"6 18
Diabetic rabbits
e .Control 2.3 2.1–2.6 85"3 47
a,e a,e .Rubbed 0.6 0.5–0.8 138"7 17
y4 a a,e .L-NA 10 M 0.5 0.4–0.6 138"5 10
y5 a,b,c a,b,c,e .Indomethacin 10 M 5.0 4.4–5.7 57"3 11
y4 b,c,d,e a,b,c,d .L-NA 10 Mq 2.0 1.8–2.3 111"5 6
y5Indomethacin 10 M
y5  .Aminoguanidine 10 M 2.8 2.6–3.0 77"4 20
E values are expressed as a percentage of a previous depolarisationmax
with KCl 50 mM.
EC values are means and confidence limits; E values are means"50 max
S.E.M.
aSignificantly different from corresponding control value, P -0.05.
bSignificantly different from corresponding rubbed value, P -0.05.
cSignificantly different from corresponding L-NA value, P -0.05.
dSignificantly different from corresponding indomethacin value,
P -0.05.
eSignificantly different from corresponding value in control rabbits,
P -0.05.
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3. Results
 y8 y5 .5-HT 10 to 10 M induced a concentration-de-
pendent contraction of the carotid artery from either con-
 .trol or diabetic rabbits Fig. 1 . The EC of the concentra-50
tion–response curve was significantly lower in arteries
from diabetic rabbits with respect to that obtained in
arteries from control rabbits, without significant differ-
 .ences between E values Table 2 . The maximal con-max
traction induced by 5-HT was 2518"121 mg control
.  .rabbits and 2445"172 mg diabetic rabbits . In arteries
from control rabbits, mechanical removal of the endothe-
lium displaced to the left the concentration–response curve
for 5-HT without significantly changing the maximal con-
 .traction Fig. 1, Table 2 . In arteries from diabetic rabbits,
removal of the endothelium enhanced the 5-HT induced
contraction both in terms of E and EC values Fig. 1,max 50
.Table 2 . The concentration–response curve for 5-HT ob-
tained in rubbed arteries from diabetic rabbits exhibited a
lower EC and a higher E value with respect to values50 max
obtained in rubbed arteries from control rabbits Fig. 1,
.Table 2 .
 y4 .Incubation with L-NA 10 M enhanced the contrac-
tions induced by 5-HT in arterial segments from both
 .  .control Fig. 2 and diabetic Fig. 3 rabbits. The maximal
contraction in response to 5-HT in L-NA-treated arteries
from diabetic animals was significantly higher than that
obtained in arterial segments from control rabbits Table
.2 .
 y5 .Incubation with aminoguanidine 10 M did not sig-
nificantly modify the contractile action of 5-HT in arterial
Fig. 2. Concentration–contraction response curves for 5-HT in carotid
arteries isolated from control rabbits in different experimental conditions:
 .  y4 .control, without endothelium rubbed , incubated with L-NA 10 M ,
 y5 .  y4incubated with indomethacin 10 M , incubated with L-NA 10
.  y5 .  y5M qindomethacin 10 M and incubated with aminoguanidine 10
.M . Values represent means"S.E.M.
Fig. 3. Concentration–contraction response curves for 5-HT in carotid
arteries isolated from diabetic rabbits in different experimental condi-
 .  y4tions: control, without endothelium rubbed , incubated with L-NA 10
.  y5 .  y4M , incubated with indomethacin 10 M , incubated with L-NA 10
.  y5 .  y5M qindomethacin 10 M and incubated with aminoguanidine 10
.M . Values represent means"S.E.M..
 .segments isolated from either control Fig. 2 or diabetic
 .Fig. 3 rabbits.
The incubation of carotid arteries from both control
 .  .Fig. 2 and diabetic Fig. 3 rabbits with indomethacin
 y5 .10 M significantly inhibited the concentration–re-
sponse curve for 5-HT, both in terms of EC and E50 max
values, with respect to that obtained either in control,
 .rubbed or L-NA preincubated arterial segments Table 2 .
The maximal contraction in response to 5-HT in indo-
methacin-treated arteries from control animals was signifi-
cantly lower than that obtained in arterial segments from
 .diabetic rabbits Table 2 .
 y4 .In the presence of both L-NA 10 M and indo-
 y5 .methacin 10 M , the concentration–response curve for
5-HT obtained in carotid arteries from control rabbits
exhibited an E significantly higher than that obtained inmax
arteries preincubated with indomethacin alone and an EC50
significantly lower than that obtained both in control and
 .indomethacin-treated arteries Fig. 2, Table 2 .
 .In arteries isolated from diabetic rabbits Fig. 3 , the
E of the concentration–response curve for 5-HT ob-max
tained in the presence of both L-NA and indomethacin was
significantly higher than that obtained either in the absence
of both inhibitors or in the presence of indomethacin alone
and was significantly lower with respect to that obtained in
 .either rubbed or L-NA-treated arteries Table 2 . The EC50
obtained in arterial segments preincubated with both in-
hibitors was significantly higher than that obtained in
rubbed and L-NA-treated arteries and significantly lower
than that obtained in indomethacin-treated arteries Table
.2 . When compared with responses induced in L-NAq
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indomethacin-treated arteries from control animals, the
EC was significantly higher in arterial segments from50
diabetic rabbits without there being significant differences
 .in the E values Table 2 .max
Table 2 summarises the E and EC values ofmax 50
concentration–response curves for 5-HT under the differ-
ent experimental conditions.
4. Discussion
The influence of alloxan-induced diabetes on the modu-
latory role of the endothelium in the constrictor response
of rabbit carotid artery to 5-HT was examined. Alloxan is
a diabetogenic agent that induces in the animal a syndrome
resembling type-I diabetes mellitus, characterised by hy-
perglycaemia, hypercholesterolaemia, glycosuria, and
raised levels of glycosylated haemoglobin in erythrocytes
 .Agrawal et al., 1987 , and it is commonly used as a valid
¨experimental model of diabetes in the rabbit Ozturk et al.,¨
.1996 .
The present results show that 5-HT strongly contracted
carotid arteries isolated from control rabbits. Alloxan-in-
duced diabetes potentiated the contractile action of 5-HT
on the carotid artery, as can be deduced from the statisti-
cally significant displacement to the left of the concentra-
tion–response curve. This would be in agreement with the
diabetes enhancement of the pressor response to 5-HT in
 .the pulmonary circulation El Kashef, 1996 and the en-
hanced sensitivity of the basilar artery to 5-HT observed in
 .short-term diabetic rats Van Buren et al., 1998 . In arter-
ies from control rabbits, the elimination of the endothelial
cell layer by rubbing of the internal surface potentiated the
contractile activity of 5-HT, thus indicating that the en-
dothelium partially counteracts this response. The endothe-
lial modulation of the 5-HT-induced contraction has been
reported in previous works Miranda et al., 1993; Valentin
.et al., 1996 . In rubbed arteries from diabetic animals, a
greater potentiation of the 5-HT-induced contraction with
respect to control rabbits was observed. This result would
indicate that diabetes enhances the inhibitory influence of
the endothelium on 5-HT-induced contractions in rabbit
carotid artery. This enhancement in the modulatory activity
of the endothelium is in agreement with some reports that
show an enhanced endothelium-dependent relaxation in
 .response to histamine White and Carrier, 1986 and to
 .acetylcholine Bhardwaj and Moore, 1988; Pieper, 1999
in diabetes. However, this result also suggests the exis-
tence of a diabetes-induced hyperreactivity of the carotid
arterial smooth muscle to 5-HT that would be partially
deadened by the enhanced modulatory activity of the
endothelium.
We studied the possibility that the modulatory action of
the endothelium could be achieved, at least partially,
through the release of NO. NO is synthesised from the
amino acid L-arginine by the Ca2q-dependent enzyme NOS.
There are three isoenzymes of NOS Moncada et al.,
.  .1997 : two constitutive isoforms, endothelial eNOS and
 .neuronal nNOS and one iNOS. Incubation of carotid
arteries with the inhibitor of the constitutive NOS L-NA
significantly enhanced the contractile response of arterial
segments to 5-HT. Because the response of the L-NA-
treated carotid arteries to 5-HT was significantly higher in
arterial segments from diabetic rabbits than in those from
control rabbits, it can be deduced that NO was more
effective at inhibiting diabetic than control arteries, indicat-
ing a greater modulatory role of NO in the diabetic state.
This would be in agreement with studies of diabetic rats
showing that diabetes-induced endothelial dysfunction re-
sults, in part, from an increase in NO production during
 .the course of the disease Pieper et al., 1998 . An exces-
sive NO production has also been suggested to contribute
to the renal hyperfiltration and hyperperfusion that charac-
terise early diabetic nephropathy Sugimoto et al., 1998;
.Choi et al., 1999 .
The expression of iNOS has been described in several
pathological conditions. iNOS has been suggested to par-
ticipate in the pathophysiology of certain vascular disor-
ders Sayama et al., 1998; Nogawa et al., 1998; Forster et
.al., 1999 . It has also been suggested that iNOS could play
 .a role in diabetic vasculopathy Stevens et al., 1997 . In
the present work, we studied the possible induction by
diabetes of NO synthesis in the carotid artery by obtaining
concentration–response curves for 5-HT in the presence of
aminoguanidine, an inhibitor of iNOS. The results ob-
tained showed that aminoguanidine did not significantly
modify the vascular response to 5-HT, thus excluding the
participation of an inducible source of NO in the carotid
arterial bed of diabetic rabbits. This result is in agreement
with the absence of an inhibitory effect of aminoguanidine
on the enhanced relaxant response to ACh of rat aortic
rings in the early stages of the streptozotocin-induced
 .diabetes Pieper, 1999 .
In the present work, we also examined the participation
of a derivative from arachidonic acid via cyclooxygenase
in the modulation of the response of the carotid artery to
5-HT by obtaining concentration–response curves for this
amine in the presence of the inhibitor of the enzyme
 .cyclooxygenase indomethacin Moncada and Vane, 1979 .
The results obtained show that indomethacin significantly
inhibited the 5-HT-induced contraction in arteries from
both control and diabetic rabbits, thus suggesting that the
contractile carotid response to 5-HT is modulated, in addi-
tion to NO, by the release of a vasoconstrictor prostanoid
 .i.e., thromboxane A . Because the response of the indo-2
methacin-treated carotid arteries to 5-HT was significantly
lower in arterial segments from control rabbits than in
those from diabetic rabbits, it can be deduced that this
vasoconstrictor prostanoid has lower modulatory activity
in the diabetic state. This would be in agreement with
studies performed in diabetic rats suggesting a decreased
formation of thromboxane A in the mesenteric arterial2
 .bed of diabetic rats Makino and Kamata, 1998 .
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In the presence of both inhibitors, L-NA and indo-
methacin, the 5-HT-induced contraction of arteries from
diabetic rabbits was significantly higher than that obtained
both in the absence of the inhibitors and with indo-
methacin alone and was significantly lower than contrac-
tions obtained in the presence of L-NA alone. In spite of
the absence of statistical differences in some comparisons,
a similar tendency was obtained in arteries from control
rabbits.
In summary, diabetes enhances the sensitivity of the
rabbit carotid artery to 5-HT. In control animals the en-
dothelium modulates the arterial response to 5-HT by the
release of both NO and a vasoconstrictor prostanoid. Dia-
betes enhances endothelial constitutive NO activity and
impairs the production of the endothelial vasoconstrictor.
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